Accendra Health Statistics
Total Valuation
Accendra Health has a market cap or net worth of $15.74 million. The enterprise value is $1.84 billion.
| Market Cap | 15.74M |
| Enterprise Value | 1.84B |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Accendra Health has 76.90 million shares outstanding. The number of shares has decreased by -0.61% in one year.
| Current Share Class | 76.90M |
| Shares Outstanding | 76.90M |
| Shares Change (YoY) | -0.61% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 9.79% |
| Owned by Institutions (%) | 78.31% |
| Float | 56.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| Forward PS | 0.01 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.72 |
| EV / EBITDA | 7.58 |
| EV / EBIT | 154.75 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.41
| Current Ratio | 0.41 |
| Quick Ratio | 0.20 |
| Debt / Equity | n/a |
| Debt / EBITDA | 5.68 |
| Debt / FCF | n/a |
| Interest Coverage | 0.09 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 0.24% |
| Return on Invested Capital (ROIC) | 0.84% |
| Return on Capital Employed (ROCE) | 0.85% |
| Weighted Average Cost of Capital (WACC) | 6.00% |
| Revenue Per Employee | $392,578 |
| Profits Per Employee | -$26,394 |
| Employee Count | 6,500 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 19.54 |
Taxes
| Income Tax | -25.72M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.89% in the last 52 weeks. The beta is 1.62, so Accendra Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.62 |
| 52-Week Price Change | -93.89% |
| 50-Day Moving Average | 0.62 |
| 200-Day Moving Average | 2.19 |
| Relative Strength Index (RSI) | 27.33 |
| Average Volume (20 Days) | 4,101,155 |
Short Selling Information
The latest short interest is 9.11 million, so 11.84% of the outstanding shares have been sold short.
| Short Interest | 9.11M |
| Short Previous Month | 8.90M |
| Short % of Shares Out | 11.84% |
| Short % of Float | 16.21% |
| Short Ratio (days to cover) | 5.23 |
Income Statement
In the last 12 months, Accendra Health had revenue of $2.55 billion and -$171.56 million in losses. Loss per share was -$2.24.
| Revenue | 2.55B |
| Gross Profit | 1.13B |
| Operating Income | 11.89M |
| Pretax Income | -148.66M |
| Net Income | -171.56M |
| EBITDA | 242.79M |
| EBIT | 11.89M |
| Loss Per Share | -$2.24 |
Balance Sheet
The company has $26.61 million in cash and $1.85 billion in debt, with a net cash position of -$1.82 billion or -$23.73 per share.
| Cash & Cash Equivalents | 26.61M |
| Total Debt | 1.85B |
| Net Cash | -1.82B |
| Net Cash Per Share | -$23.73 |
| Equity (Book Value) | -568.23M |
| Book Value Per Share | -7.39 |
| Working Capital | -397.58M |
Cash Flow
In the last 12 months, operating cash flow was -$25.31 million and capital expenditures -$173.81 million, giving a free cash flow of -$199.12 million.
| Operating Cash Flow | -25.31M |
| Capital Expenditures | -173.81M |
| Depreciation & Amortization | 230.90M |
| Net Borrowing | -235.70M |
| Free Cash Flow | -199.12M |
| FCF Per Share | -$2.59 |
Margins
Gross margin is 44.13%, with operating and profit margins of 0.47% and -6.72%.
| Gross Margin | 44.13% |
| Operating Margin | 0.47% |
| Pretax Margin | -5.83% |
| Profit Margin | -6.72% |
| EBITDA Margin | 9.51% |
| EBIT Margin | 0.47% |
| FCF Margin | n/a |
Dividends & Yields
Accendra Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.61% |
| Shareholder Yield | 0.61% |
| Earnings Yield | -1,096.12% |
| FCF Yield | -1,274.82% |
Analyst Forecast
The average price target for Accendra Health is $1.26, which is 516.51% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.26 |
| Price Target Difference | 516.51% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | -0.95% |
| EPS Growth Forecast (3Y) | -36.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 1, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Apr 1, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |